Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP-786 PK and Safety Study in Healthy Volunteers
NCT02174835Phase 1Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Sep 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of deudextromethorphan in agitation (2 cohorts), sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoint: Plasma concentrations of AVP-786 at 7 days. Started Sep 2013; status: completed.
02
Drugs
deudextromethorphan
03
Conditions
agitation
Beyond the preview
Go deeper on NCT02174835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174835.